The Global Cancer Monoclonal Antibodies Market Size was $55,640.00 million in 2021 and is predicted to grow with a CAGR of 7.0%, by generating a revenue of $106,825.10 million by 2031. Impact Analysis of COVID-19 on Cancer Monoclonal Antibodies Market The cancer monoclonal antibodies sector has suffered due to the COVID-19 pandemic. The COVID-19 pandemic has had a severe influence on...